Peto, Daniela
Schmidmeier, Florian
Katzdobler, Sabrina
Fietzek, Urban M.
Levin, Johannes
Wuehr, Max http://orcid.org/0000-0001-5115-3777
Zwergal, Andreas
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EO1401, 13GW0490B)
Klinikum der Universität München
Article History
Received: 23 April 2024
Revised: 5 June 2024
Accepted: 7 June 2024
First Online: 17 June 2024
Declarations
:
: JL reports speaker fees from Bayer Vital, Biogen and Roche, consulting fees from Axon Neuroscience and Biogen, author fees from Thieme medical publishers and W. Kohlhammer GmbH medical publishers, non-financial support from Abbvie and compensation for duty as part-time CMO from MODAG, outside the submitted work. MW received funding from the neuroConn GmbH (DC stimulator). He serves as an associate editor for Frontiers in Neurology—Section Neuro-otology and Section Translational Research in Rehabilitation. AZ reports speaker fees and research support from Dr. Willmar Schwabe GmbH. He serves as an associate editor for Frontiers in Neurology—Section Neuro-otology and Section Translational Research in Rehabilitation.
: The ethics committee of the medical faculty of the Ludwig-Maximilians-University approved the study protocol (20-1137), which was conducted in accordance with the Declaration of Helsinki.